Novartis Investigative Site

Aomori 030 8553

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Secondary Progressive Multiple Sclerosis

Studies at this site

• Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop) — Completed
• Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs — Completed
• Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) — Completed
• A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) — Completed